These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 7763311

  • 1. Intracellular metabolism of 2',3'-dideoxynucleosides in duck hepatocyte primary cultures.
    Kitos TE, Tyrrell DL.
    Biochem Pharmacol; 1995 May 11; 49(9):1291-302. PubMed ID: 7763311
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2',3'-dideoxyguanosine 5'-triphosphate to the viral polymerase.
    Howe AY, Robins MJ, Wilson JS, Tyrrell DL.
    Hepatology; 1996 Jan 11; 23(1):87-96. PubMed ID: 8550054
    [Abstract] [Full Text] [Related]

  • 3. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
    Zoulim F, Dannaoui E, Borel C, Hantz O, Lin TS, Liu SH, Trépo C, Cheng YC.
    Antimicrob Agents Chemother; 1996 Feb 11; 40(2):448-53. PubMed ID: 8834896
    [Abstract] [Full Text] [Related]

  • 4. Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
    Balzarini J, Baba M, Pauwels R, Herdewijn P, Wood SG, Robins MJ, de Clercq E.
    Mol Pharmacol; 1988 Mar 11; 33(3):243-9. PubMed ID: 3258404
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides.
    Suzuki S, Lee B, Luo W, Tovell D, Robins MJ, Tyrrell DL.
    Biochem Biophys Res Commun; 1988 Nov 15; 156(3):1144-51. PubMed ID: 3190693
    [Abstract] [Full Text] [Related]

  • 6. The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver.
    Fourel I, Saputelli J, Schaffer P, Mason WS.
    J Virol; 1994 Feb 15; 68(2):1059-65. PubMed ID: 8289335
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.
    Rahn JJ, Kieller DM, Tyrrell DL, Gati WP.
    Antimicrob Agents Chemother; 1997 May 15; 41(5):918-23. PubMed ID: 9145844
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nucleobase transporter-mediated permeation of 2',3'-dideoxyguanosine in human erythrocytes and human T-lymphoblastoid CCRF-CEM cells.
    Gati WP, Paterson AR, Tyrrell DL, Cass CE, Moravek J, Robins MJ.
    J Biol Chem; 1992 Nov 05; 267(31):22272-6. PubMed ID: 1429579
    [Abstract] [Full Text] [Related]

  • 12. Structural analysis of 2',3'-dideoxyinosine, 2',3'-dideoxyadenosine, 2',3'-dideoxyguanosine and 2',3'-dideoxycytidine by 500-MHz 1H-NMR spectroscopy and ab-initio molecular orbital calculations.
    Plavec J, Koole LH, Chattopadhyaya J.
    J Biochem Biophys Methods; 1992 Dec 05; 25(4):253-72. PubMed ID: 1337354
    [Abstract] [Full Text] [Related]

  • 13. In vitro antiviral activities of Chinese medicinal herbs against duck hepatitis B virus.
    Leung KT, Chiu LC, Lam WS, Li Y, Sun SS, Ooi VE.
    Phytother Res; 2006 Oct 05; 20(10):911-4. PubMed ID: 16892461
    [Abstract] [Full Text] [Related]

  • 14. 2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line.
    Magnani M, Brandi G, Casabianca A, Fraternale A, Schiavano GF, Rossi L, Chiarantini L.
    Biochem J; 1995 Nov 15; 312 ( Pt 1)(Pt 1):115-23. PubMed ID: 7492300
    [Abstract] [Full Text] [Related]

  • 15. The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.
    Balzarini J, De Clercq E.
    Biochem Biophys Res Commun; 1989 Feb 28; 159(1):61-7. PubMed ID: 2538128
    [Abstract] [Full Text] [Related]

  • 16. Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside.
    Pauwels R, Baba M, Balzarini J, Herdewijn P, Desmyter J, Robins MJ, Zou RM, Madej D, De Clercq E.
    Biochem Pharmacol; 1988 Apr 01; 37(7):1317-25. PubMed ID: 3258516
    [Abstract] [Full Text] [Related]

  • 17. The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
    Balzarini J, Pauwels R, Baba M, Robins MJ, Zou RM, Herdewijn P, De Clercq E.
    Biochem Biophys Res Commun; 1987 May 29; 145(1):269-76. PubMed ID: 3496089
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus.
    Lee B, Luo WX, Suzuki S, Robins MJ, Tyrrell DL.
    Antimicrob Agents Chemother; 1989 Mar 29; 33(3):336-9. PubMed ID: 2729928
    [Abstract] [Full Text] [Related]

  • 20. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
    Placidi L, Faraj A, Loi AG, Pierra C, Egron D, Cretton-Scott E, Gosseli G, Périgaud C, Martin LT, Schinazi RF, Imbach JL, el Kouni MH, Bryant ML, Sommadossi JP.
    Antivir Chem Chemother; 2001 Mar 29; 12(2):99-108. PubMed ID: 11527047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.